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In general, the production of immunoglobulins by plasma cells (1-5)  involves the 
same operations and  pathway as  the  production of secretory proteins by cells of 
exocrine and endocrine glands (6, 7)-i.e., synthesis on attached polysomes followed by 
segregation in thecisternal space of  the rough endoplasmic reticulum (ER),I packaging 
in the Golgi,  and discharge by exocytosis. The main difference is that, whereas in 
glandular cells secretory  products are concentrated (up to 50-150  times [6-8]) and 
packaged into morphologically recognizable secretion  granules that  can be stored 
before discharge, there is usually little (if any) concentration or intracellular storage 
of immunoglobulins (5). They appear  to be packaged in dilute solution in small, 
membrgpe-limited vesicles that continually release  their content by exocytosis.  Be- 
cause such vesicles cannot be distinguished morphologically from other vesicles (e.g., 
endocytic vesicles) with a different content, their identification as immunoglobulin 
carriers  has been inferred from results obtained by cell fractionation (1), autoradiog- 
raphy  (9), and  especially  by  immunostaining (10-12).  In  both  immunoglobulin- 
secreting cells and cells of exocrine and endocrine glands, secretion, therefore, involves 
the continual insertion of a considerable amount of Golgi-derived membrane into the 
plasmalemma at  the time of exocytosis.  In glandular cells, it  has been  repeatedly 
demonstrated (13-15) that, after exocytosis, membrane is continually removed from 
the cell surface by endocytosis to maintain a  constant cell size. Evidence obtained 
recently on several exocrine  and endocrine cell types indicates that at least some of 
the membrane retrieved from the cell surfaces  fuses with multiple cisternae of the 
Golgi stacks (14-18) and suggests that the recovered membrane may be reused in the 
packaging of newly synthesized secretory products (15). 
The purpose of this study is to determine whether or not membrane is similarly 
retrieved  from the  surface  of immunoglobulin-secreting cells  and  returned  to  the 
Golgi complex: Because these ceils do not concentrate their product and exocytosis is 
a continual process, it seemed likely that membrane traffic (from Golgi to cell surface 
and back) might be relatively extensive. If this assumption were proved to be correct, 
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immunoglobulin-secreting cells would represent a convenient system for investigating, 
in further detail, mechanisms and pathways of membrane recycling in secretory cells. 
Established cell lines are available, they provide the usual advantages of homogeneous 
cell populations in which all cells are uniformly accessible to experimental  variables, 
they can be easily grown in culture, and they can be produced in quantities sufficient 
for cell fractionation and subsequent biochemical studies. With this in mind, we have 
used  immunocytochemical  procedures  to  localize  the  secretory  compartment  and 
various tracers to follow the pathway of membrane recovered from the cell surface, 
and have carried out studies on both mature plasma cells harvested from lymph nodes 
and myeloma cell lines. The results reveal an active and continuous membrane traffic 
from the cell surface to the Golgi complex and lysosomes in immunoglobulin-secreting 
cells, which is, in general, comparable to that previously documented in exocrine and 
endocrine cells (14-18). 
Materials  and Methods 
Media  and  Chemicals.  Cell  culture  media,  sera,  antibiotics,  and  Freund's  complete  and 
incomplete adjuvant were obtained from Grand Island Biological Co., Grand Island, N.  Y.; 
native and cationized ferritin  (CF), from Miles Laboratories Inc., Elkhart,  Ind.; horseradish 
peroxidase (HRP) (types II and VI), diaminobenzidine (DAB), andp-nitrocatechol sulfate were 
obtained  from Sigma Chemical  Co.,  St.  Louis,  Mo.;  Fab  fragments of sheep  antibodies  to 
mouse immunoglobulins coupled to peroxidase from the Pasteur Institute,  Paris  (19);  L-[4,5- 
aH]ieucine from Schwarz/Mann Div., Amersham, England (40-60 Ci/mM sp act). All other 
chemicals were of reagent grade. Ferritin with isoelectric  points of narrow range were provided 
by Dr. Y. S. Kanwar (20). Native ferritin was dialyzed (in two to three changes of phosphate 
buffer) before use. The isoelectric  points (pI) of HRP was determined by isoelectric  focusing in 
Sephadex gel  (Pharmacia Fine Chemicals,  Div. of Pharmacia,  Inc., Piscataway, N. J.)  (21). 
Both Sigma type II and type VI HRP exhibited several  bands with the major band having an 
apparent pI of-7.8 (22). 
Plasma Cells.  Normal plasma cells were obtained from rats immunized with HRP following 
the procedure of Miller et al. (23). Young male rats (Charles River Breeding Laboratories, Inc., 
Wilmington, Mass.)  were immunized with 0.5  mg HRP (Sigma type VI) in either complete 
(first  injection)  or incomplete  Freund's adjuvant  in  each  hind  foot pad.  The  animals  were 
primed several times and boosted 1 wk before the experiment. Both popliteal lymph nodes were 
excised  under  phenobarbital  anesthesia  (7.5  mg/100 g  body we), dissected  free of fat,  and 
transferred to Dulbecco's phosphate-buffered saline (PBS) where they were cut into small pieces 
with a razor blade, and subsequently teased with a pair of fine forceps.  The teased tissue  was 
then filtered successively through a 250-#m, followed by 70-/xm, nylon mesh, which resulted in 
complete dispersion  into a  cell  suspension.  The cells  were washed  three  times  in  PBS  and 
resuspended in Dulbecco's modified Eagle's medium (DMEM). Siliconized tubes and pipettes 
were used to prevent sticking.  Immunodiffusion carried out on serum from immunized animals 
showed high titers of precipitating antibodies against HRP. 
Myleoma Cell Lines.  Three different mouse myeloma cell  lines  were studied:  RPC 5.4 and 
X63 Ag 8 were obtained as a gift from Dr. F.  Ruddle, and MOPC 315 as a gift from Dr. M. 
Armstrong (both of Yale University, New Haven, Conn.). Cells were grown in tissue  culture 
bottles or Petri dishes in DMEM without sodium pyruvate, which contained 4,500 mg glucose/ 
liter  and  was  supplemented  with  nonessential  amino  acids,  penicillin  (1,000  U/100  ml), 
streptomycin (10 rag/100 ml), and either 20% heat-inactivated horse serum (X63 Ag 8) or 15% 
heat-inactivated fetal  bovine serum  (RPC 5.4 and MOPC 315). Cells were harvested during 
exponential growth. 
Labeling  of Cells  with  Tracer Proteins.  Cells  were  washed  twice  (by  sedimentation  and 
resuspension)  in DMEM before addition of tracers. Incubation of lymph node cells was carried 
out  in siliconized conical glass centrifuge tubes  at  a  concentration of 10-20 ×  106 cells/ml. 
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centrifuge tubes or in small Petri dishes  (which contained 2 ml medium) at a concentration of 
5-6 ×  10  n cells/ml. Incubations were at 0 °, 25 °, or 37°C in an atmosphere of 93% air/7% COs 
for periods of 2 min to several hours. CF was used at  a  concentration of O.1  mg/ml in the 
plasma cell experiments and 0.05 mg/ml in the myeioma cell experiments. Some myeloma cells 
were  also exposed  to native (anionic) ferritin at a  concentration of 5-10 mg/ml or to HRP 
(Sigma type II or type VI) at a concentration of 1.0 mg/ml. Still others were exposed to both 
CF and HRP as follows: they were incubated first with CF (0.05 mg/ml) at 0°C, after which 
they were sedimented (by spinning  at 1,000 g for 3 min) at 0°C, and resuspended and incubated 
in HRP (1.0 mg/ml) at 37°C. 
Processing of Cells  for Electron Microscopy.  Cells exposed to ferritin were fixed in suspension by 
adding one part 2% glutaraldehyde in 0.1 M caeodylate buffer (pH 7.4), or Karnovsky's fixative 
(1.6% paraformaldehyde and  3%  glutaraldehyde in 0.1  M  cacodylate  buffer)  to  one  part 
medium. After fixation (1-2 h  at  room temperature), they were sedimented in a  Beckman 
Microfuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.), and the resultant pellets 
were postfixed in OsO4 in acetate-veronal buffer (45 min at 4°C), dehydrated in ethanol, and 
embedded in Epon. Cells exposed to HRP were fixed in 1% glutaraldehyde for  1-2 h at 0°C, 
washed overnight in 0.1 M caeodylate buffer, and incubated in DAB (24), postfixed in OsO4, 
and embedded for electron microscopy as already described. 
Aryl Sulfatase Tests.  Myeloma cells  (RPC 5.4) were fixed  (10 min at 4°C) by adding .one 
part  1% glutaraldehyde in 0.1 M cacodylate buffer to one part medium, after which the cells 
were pelleted, and washed (by sedimentation and resuspension) in 0.1 M cacodylate buffer that 
contained 7% sucrose.  Incubation was carried out for aryl sulfatase (90 min at 25°C) with p- 
nitrocateehol sulfate as substrate at pH 5.5, according to Bentfieid-Barker and Bainton's (25) 
modification of Goldfischer's (26) method. 
Immunocytochemist~.  Lymph node or myeloma ceils were fixed by adding one part Karnov- 
sky's fixative to one part medium (20 rain at room temperature), after which they were washed 
several  times in Tris-buffered saline (to  quench aldehyde groups), and pelleted in 3% warm 
(~40°C) agar. The agar was allowed to solidify, and the resultant agar-embedded pellet was 
incubated for 1 h in Tris-buffered saline that contained 10% dimethylsulfoxide. The pellet was 
then  frozen  in  isopentane cooled  down  to  its  melting point  (-160°C)  in  liquid nitrogen. 
Cryostat sections (I-8/tm) were prepared with a conventional  cryostat at -18°C and collected 
in PBS that contained 0.1% bovine serum albumin. Sections of lymph node cells were incubated 
in PBS  that contained 10-20/xg/ml HRP (Sigma type VI) at  room temperature for  1 h  to 
demonstrate intracellular  sites of anti-HRP antibodies (12), after which they were washed three 
times in PBS and incubated for 30 min in DAB-containing  medium (24). Sections of myeloma 
cells were  incubated for  1 h  at room temperature in peroxidase-conjugated anti-mouse Fab, 
washed in PBS, and incubated in DAB, as described for sections of plasma cells to demonstrate 
intracellular  sites of mouse immunoglobulins  (27). 
Evaluation of the Effect of CF on Cell Viability and Secretion.  To determine whether or not CF 
had a toxic effect on myeioma cells, we carried out trypan blue exclusion tests, assayed lactic 
dehydrogenase activity (LDH) (28) released into the medium, and measured rates of secretion 
of labeled products (after pulse-labeling of the cells  [5]) in myeloma cells  incubated in the 
presence and absence of CF. The number of trypan blue-stained cells, the LDH detected, and 
the rate of release of labeled proteins into the medium varied from cell line to cell line and from 
one experiment to another, but in a given experiment there was little or no difference between 
results  obtained  on  cells  incubated with  CF  as  compared  with  controls.  In  one  typical 
experiment the amount of LDH found in the medium of cells incubated for  1 h with CF was 
70 U/liter (_ 26 SD)  for RPC 5.4 cells and 14 U/liter (± 6.5 SD) for X63 Ag 8 cells, whereas 
the  corresponding figures  in  controls  were  77  (+  12.5 SD)  and  12  U/liter  (_  5.5  SD), 
respectively.  The rate of cell death as estimated by LDH release  amounted to ~0.1-0.5%/h. 
The rate of secretion from cells incubated with CF was 5.8%/hour (±  1.9) for cells of the RPC 
5.4 cell  line and 6.9%/hour (±  1.0) for X63 Ag 8 cells, and the corresponding figures from 
controls were 4.2 (±  1.1) and 5.1% (±  1.6), respectively. 
Results 
Plasma Cells 
Although myeloma cells were used for most of our tracer studies, we also did some 
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(a)  whether  normal  plasma  cells  behaved  in  the  same  way  with  respect  to  their 
handling of CF as cells of the anterior pituitary (15,  16) and thyroid (17)  glands, and 
(b) whether or not myeloma cells maintained in culture behaved in the same manner 
as normal,  nonmalignant  plasma cells.  As a  source of plasma cells we used  lymph 
node cells harvested from rats immunized with HRP because the secretory compart- 
ments of these cells (which contain anti-HRP immunoglobulins) can be easily labeled 
by incubating the cells with HRP (11,  12). 
EXPERIMENTS WITH CF.  When lymph node cells were incubated with CF at either 
0 °  or 37°C,  the tracer bound to the surfaces of both lymphocytes and plasma cells. 
Lymphocytes tended to clump together and occasionally showed capping, but aggre- 
gation or capping of mature plasma cells was never observed. CF bound to the cell 
membranes of plasma cells in a relatively uniform layer (Fig.  1), and when these cells 
were incubated at 37°C after binding, there was extensive uptake of the bound CF by 
endocytosis (Fig.  1). During incubation periods of 10-60 min there was a progressive 
increase in the amount of CF found in the Golgi region where it was located in small 
vesicles, in larger vacuoles, and in multiple stacked Golgi cisternae (Figs. 2-4). Once 
within  these  compartments  the  CF  typically  occurred  as  small  aggregates  that 
remained at least partly membrane associated. Small vesicles that contained CF were 
seen in the Golgi region as early as 5-10 min after addition of the tracer, and CF was 
observed in the stacked Golgi cisternae by 20 min. The uptake and fate of the tracer 
was the same as that demonstrated  previously in anterior pituitary cells:  namely, it 
binds  to the cell  membrane,  is  then  internalized  by endocytosis, and  the  resultant 
endocytic vesicles that contain the tracer eventually fuse with multiple stacked Golgi 
cisternae  and  presumptive secretory vacuoles in  the  Golgi  region.  In  plasma cells, 
however, there are typically fewer recognizable lysosomes than in dissociated pituitary 
cells and relatively little evidence of uptake of CF into lysosomes. 
LOCALIZATION  OF  INTRACELLULAR  IMMUNOGLOBULINS  (ANTI-HRP  ANTIBODIES). 
When  lymph  node  cells  from  rats  immunized  with  HRP  were  sectioned  in  a 
cryostat and incubated first with HRP and then with DAB to reveal the intracellular 
localization of antibodies to HRP, ~5% of the cells, which were mature plasma cells, 
were stained. As reported by others (11,  12), there was a general and intense staining 
of the rough ER, including the perinuclear cisterna, as well as the Golgi cisternae and 
associated vesicles (Fig. 5). It is noteworthy that many of the small vesicles located on 
both the cis and trans side of the Golgi were also stained, but a  few were not. The cell 
surfaces of most plasma cells were not stained. When cells were exposed to CF before 
staining, the tracer was often detected in Golgi cisternae that  also contained stained 
immunoglobulins  (Fig.  6),  which  indicates  that  the  incoming  endocytic  vesicles 
carrying CF fuse with elements along the secretory pathway. 
Myeloma Cells 
MORPHOLOOV.  A number of mouse myeloma cell lines were screened initially. Of 
these, three were chosen for use in these experiments because the cells have extensive, 
well-developed Golgi complexes; those selected were two IgG-secreting lines, RPC 5.4 
and X63 Ag 8, and the IgA-secreting myeloma, MOPC 315. All three have a similar 
morphology and are characterized by a  rather extensive rough ER that is dilated in 
many regions and contains virus particles  (of the C-type) budding into the cisternal 
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Fins. 1-4.  Portions of plasma cells fixed after incubation in CF (0.05 mg/ml). Fig. I shows that CF 
binds in a relatively uniform layer to the cell membrane (arrow) and is taken up in endocytic vesicles 
(re). Fig. 2 shows that after incubation in CF for 60 min considerable CF is present in the Golgi 
region where it is located within vesicles (ve) or vacuoles (v) of varying size and within several Golgi 
(G)  cisternae (arrows). Figs. 3 and 4 are higher magnification views showing CF molecules within 
several of the stacked Golgi cisternae (arrows) as well as in vesicles (ve)  located nearby, er, rough 
ER; m, mitochondria; N, nucleus. Figs. 1, 3, and 4: ×  76,000.  Fig. 2: ×  16,000. MEMBRANE  PATHWAYS  IN  PLASMA  CELLS  AND  MYELOMA  CELLS 
Fro.  5.  Plasma cell from the lymph node of a  rat immunized with HRP showing the distribution 
of anti-HRP  immunoglobulin as demonstrated  by  immunostaining. Immunoglobulin is  present 
throughout the rough ER (er)  including the perinuclear cisternae (pc), in the stacked Golgi cisternae 
(G),  and  in  small  vesicles or  vacuoles  (v)  in  the Golgi  region.  Other small vesicles (ve)  are  not 
stained. The specimen was fixed in glutaraldehyde, sectioned on a  cryostat, and  incubated with 
HRP, followed by staining in DAB. m, mitochondria; N, nucleus. X 22,000. 
FIG. 6.  Golgi region from a  plasma cell from the same experiment as in Fig. 5 except that the 
cell had been incubated with CF for 60 min before fixation and immunostaining. Immunogiobulin 
is present throughout  the stacked Golgi cisternae (G).  Note  the presence of CF molecules in one 
cisterna that also contains immunoglobulins (arrow).  X  75,000. P.  D.  O'I-I'OSEN, P.  J.  COURTOY,  AND MI  G.  FARQUHAR 
Figs.  2  and  7),  and  free polysomes  are  much  more  abundant.  The  Golgi complexes 
typically consist  of three  to six  stacked  cisternae  found  near one pole of the nucleus 
(Fig.  7). The X63 Ag 8  cells have the fewest  (2-4)  cisternae, and  the MOPC  315  and 
RPC  5.4 have more (4-6). A  few lysosomes are typically seen in the Golgi region, and 
FxG.  7.  Portion of a mouse myeloma cell (RPC 5.4) demonstrating the presence  of an extensive 
Golgi complex (G) consisting  of three to six stacked cisternae.  A centriole (ce), a lysosome (ly), and 
numerous small vesicles (ve) are seen on the trans  (concave)  side of the Golgi. A number of dilated 
cisternae  of the rough ER (er) are present.  Typically, some of them contain viral particles as seen 
here  to  the  right  (c). Transitional  vesicles  (tr)  are  present  on  the  cis  side  of the  Golgi.  The 
mitochondria  (m)  are typically large with a  matrix of low density and  relatively few cristae.  N, 
nucleus.  X 15,000. MEMBRANE PATHWAYS IN PLASMA CELLS AND MYELOMA CELLS 
many transitional  vesicles are present on the cis side of the Golgi where they often 
occur in clusters closely associated with the rough ER (Fig. 9). 
EXa'ERXME~rrs WITH OF.  Initial experiments showed  that  (a)  when  the  cells were 
incubated with (IF in the presence of serum, the tracer clumped and  formed large 
aggregates, and (b) capping often occurred when the cells were incubated at 37°C in 
the  presence  of a  relatively  large  concentration  of CF  (>0.2  mg/ml),  whereas  no 
capping was observed when the concentration  was 0.05 mg/ml or less.  Accordingly, 
subsequent experiments were carried out with serum omitted at a tracer concentration 
of 0.05 mg/ml. 
When  (IF was  added  to a  suspension  of cells,  it  immediately bound  to  the  cell 
surfaces, and the cells had a tendency to agglutinate into clumps. (IF bound strongly 
to  the  cell  membrane  regardless  of the  temperature  at  which  binding  was  done; 
however,  its  distribution  varied  with  the  binding  temperature.  It  was  relatively 
uniformly distributed  along the cell surfaces when  binding was carried out at 0°C, 
but  its distribution  was more uneven  and patchy when  binding was carried out  at 
room temperature or at  37°(]  (Fig.  8).  When  cells were subsequently  incubated  at 
37°(] in the presence of (IF, the tracer was taken up by endocytosis. As in the case of 
normal plasma cells, at 2-10 min it was located mainly at the cell periphery either in 
small vesicles (some of which were coated) or in invaginations of the cell membrane 
(Fig.  8), and,  after  10 min, it was seen  in  increasing quantities  in  the Golgi region 
where  it  was  initially  located  in  small  vesicles  or  in  larger  lysosomal  structures 
(vacuoles or muhivesicular bodies)  (Fig. 9).  Later (after 20 min), it was also seen in 
the stacked Golgi cisternae in cells of the X63 Ag 8 and RPC 5.4 cell lines, but not in 
MOP(] 315 cells. The amount of CF found in the Golgi cisternae of the former two 
lines increased up to 40-60 min of incubation, at which time it was typically located 
in multiple stacked cisternae (Fig.  10). At this time it was also seen in small vesicles 
and in lysosomes as well as in tubular structures located in close proximity to lysosomes 
(Fig.  10) in cells of all three myeloma lines. In favorable sections some of these tubular 
structures were observed to be in continuity with lysosomes (Fig.  11).  As in the case 
of the  plasma cells after internalization,  the (IF had  a  tendency  to  aggregate into 
clumps or clusters that  typically remained partly associated with  the  membrane of 
the receiving compartments. 
The fact that there was variability in the findings among the major different cell 
lines with regard to the presence of(iF within Golgi cisternae was interesting. We can 
provide no explanation for this finding; however, because (IF was regularly found in 
multiple cisternae of the Golgi stacks in nonmalignant cells from lymph nodes, as well 
as in X63 Ag 8 and RP(] 5.4 myeloma cells, it appears that the behavior of MOPC 
315 myeloma cells is not typical, and, therefore, we did not use them for subsequent 
tracer experiments. 
EXPEltXMErrrs WXTH HRP.  (jells incubated in HRP showed extensive uptake of the 
tracer in  small  endocytic  vesicles where  it  was  found  staining  the content  of such 
vesicles. This  is  in  keeping with  the fact  that  HRP  is usually considered  a  reliable 
content marker for fluid-phase pinocytosis (29). After a  1-h period of incubation, the 
intracellular  distribution  of the  tracer  was  different  from  that  of (IF:  HRP  was 
observed only in lysosomes (large vacuoles and muhivesicular bodies) and in smaller 
vesicles and tubular structures  in the vicinity of lysosomes. It was never seen in the 
stacked Golgi cisternae of these cells (Fig.  12). FIGS. 8 AND 9.  Mouse myeloma cells (RPC 5.4)  fixed after incubation in CF for  10 min at 37°C. 
Fig. 8 shows CF molecules distributed in patches along the cell membrane (cm) and concentrated 
in a  coated  invagination of the surface membrane (arrow)  where it adheres to the membrane, m, 
mitochondria; er, rough ER. Fig. 9 shows the distribution of CF in the Golgi region. At this time CF 
is present in numerous small vesicles (ve), in a  muhivesicular body (my), and in lysosomes (ly), all 
of which are located on the trans side of the Golgi stack. No ferritin is seen in the Golgi cisternae (G) 
at this early time. Numerous transitional vesicles (tr) are present on the cis side of the Golgi between 
the rough ER (~r) and the Golgi cisternae (G). N, nucleus, x  75,000. 
9 FIGS. t0 AND I 1.  Fig.  10 shows mouse myeloma cells (RPC 5.4)  incubated for 60 min at 37°C in 
CF. CF is present in several stacked Golgi cisternae (arrows) and in small vesicles (ve) located near 
the Golgi cisternae or near lysosomes (ly). The two large lysosomes present in the field also contain 
considerable CF, Both lysosomes are surrounded by small vesicles or tubules that contain CF.  Fig. 
11 shows several such tubules (arrows)  in continuity with another lysosome (ly), which is filled with 
CF. A virus particle is also present within this lysosome. ×  75,000. 
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EXPERIMENTS WITH BOTH CF AND HRP.  In experiments  in which  cells were  incubated 
with both tracers, most incoming vesicles were seen to contain both CF and HRP, but 
some contained CF alone.  Surprisingly, after incubation  in  both tracers  for  1 h  at 
37°C, there was a  distinct  difference in the distribution of these two tracers within 
cell compartments: Both CF and HRP were present  together within lysosomes, but 
whereas CF was seen in the stacked Golgi cisternae, HRP was never observed in this 
location (Fig.  13). CF was also found in small vacuoles and tubular structures in the 
vicinity of lysosomes and the Golgi cisternae, many of which lacked HRP. Thus, the 
eventual destination of each tracer after a  1-h incubation was the same in the double- 
tracer experiments as when the cells were incubated in each tracer alone. These results 
indicate that the cell is somehow able to sort the two tracers in transit and to direct 
them to different compartments. 
EXPERIMENTS WITH  NATIVE (ANIONIC)  FERRITIN.  In contrast to the findings with CF, 
native ferritin did not bind to the surfaces of myeloma cells,  and very small amounts 
were taken up even after prolonged incubation (up to 6 h) at very high concentrations 
of ferritin  (5-10 mg/ml).  In addition,  the distribution of this  tracer was limited  to 
FIGS. 12 AND 13.  Fig.  12 shows a  mouse myeloma cell (RPC 5.4) incubated for 60 rain in HRP at 
37°C. HRP is seen in a  large lyso~ome (ly)  located near the Golgi cisternae (G) and in a  few small 
vesicles  (re)  located  nearby.  Note  that  no  HRP  is  present  in  the Golgl  cisternae  or  in  vesicles 
associated with it. c, virus panicle.  Fig.  13 shows a  similar cell  incubated  in both CF and  HRP. 
Both CF and  HRP are present  in  two  large lysosomes (ly).  CF is also seen within several Go|gi 
cisternae (G) and associated vesicles (ve), but these elements do not contain HRP. Fig.  12: ×  65,000. 
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lysosomes where it was found in only small amounts. It was never seen in the stacked 
Golgi cisternae. 
EXPERIMENTS WITH FERRITINS WITH VARYING PI.  When cells were incubated with 
CF (prepared as described elsewhere [20]) with pI intermediate between that of native 
ferritin (4.8) and that of the commercially available CF (>8.0), fractions with a pI of 
7.4 or less behaved like native ferritin-they did not bind to the cell surface and they 
were taken up in very small amounts into lysosomes only. Those with a  pI of 7.8 or 
more behaved like the commercial CF-they bound to the cell surface, were taken up 
in significantly greater amounts, and, after a  1-h incubation, were found not only in 
lysosomes, but also in elements of the secretory apparatus-i.e., stacked Golgi cisternae 
and associated vesicles and vacuoles. These results were very instructive because they 
indicate that the intracellular fate of ferritin depends upon whether or not it binds to 
the cell membrane and acts as a membrane or a content marker. Anionic ferritin does 
not  bind  to  myeloma or other cell  membranes  (because  they  are  also  negatively 
charged),  enters  the  cell  in  the  fluid  content  of endocytic  vesicles  (fluid-phase 
pinocytosis [30]), and ultimately appears only in lysosomes. CF  (pI >7.8)  binds by 
ionic interaction (31) to myeloma and other cell membranes, enters the cell bound to 
the inner aspect of the endocytic vesicle membrane (adsorptive pinocytosis [30]), and 
eventually appears both in the secretory and  lysosomal compartments. The fate of 
ferritin with an intermediate pI depends upon whether under the prevailing conditions 
(cell surface charge, ionic strength of the medium, and pI of the tracer) it binds to the 
cell membrane, i.e., whether it serves as a membrane or a content marker. 
IMMUNOCYTOCHEMICAL  LOCALIZATION  OF  IMMUNOGLOBULINS.  Intracellular  immu- 
noglobulins  (IgG)  were  localized  in  RPC  5.4  and  X63  Ag  8  myeloma  cells  by 
immunocytochemistry with  peroxidase-conjugated anti-mouse  Fab on cryostat sec- 
tions. IgG were regularly stained throughout the rough ER, including the perinuclear 
cisterna, throughout most of the stacked Golgi cisternae, and in a  few large vacuoles 
in the Golgi region (Fig.  14). Staining of the ER was present even in areas in which 
many intracisternal virus particles were located. In experiments in which immuno- 
cytochemical localization of IgG was carried out after exposure to CF, both the tracer 
and the IgG could be demonstrated in the same Golgi cisternae (Figs.  15 and  16). 
Thus, it was clear that, as in the case of plasma cells, the CF reached compartments 
along the secretory pathway. 
COMMENTS ON THE CONSISTENCY  OF IMMUNOCYTOCHEMICAL STAINING.  The advantage 
of  using  cryostat  sections  was  that  the  cells,  and  thereby  the  main  secretory 
compartments, are cut open (eliminating the necessity for using detergents) and thus 
directly exposed to either HRP or the labeled antibody fragment. It was clear that 
the use of cryostat sections greatly facilitated the Penetration of the immunoreagents 
because little or no intracellular staining  was  seen when  whole  (unsectioned)  cells 
were used. The consistency with which immunostaining was seen in a given compart- 
ment depended upon its extensiveness and, therefore, the frequency with which it was 
cut  open  by  cryostat  sectioning.  Thus,  the  rough  ER  (including  the  perinuclear 
cisterna),  being  the  most  extensive  and  uniformly distributed  compartment,  was 
regularly exposed and hence regularly stained in all cells. The Golgi apparatus, whose 
distribution  is  more  restricted,  was  less  regularly  cut  open  and,  accordingly,  less 
regularly stained. In myeloma cells, transitional vesicles (Figs. 4 and  14) that presum- 
ably contain secretory product were usually not stained because, owing to their small F~os: 14-16.  Immunocytochemical demonstration of IgG in myeloma cells (RPC 5.4).  In Fig.  14 
the secretory product (IgG) is present in the rough ER (er)  including the perinuclear cisterna (pc), 
and in Golgi elements. All the stacked Golgi cisternae (G)  are stained. A  large vacuole (v)  in the 
Golgi region also contains demonstrable lgG. N, nucleus; m, mitochondria. Figs. 15 and 16 are high 
magnification views of a cell incubated in CF for 60 min before fixation and the immunocytochem- 
ical localization of IgG. An area with relatively weak staining of the Golgi was chosen for illustration 
so that the CF shows up more clearly. It can be seen that CF (short arrow)  is present in the same 
cisterna which contains IgG (long arrow). CF is also located in  numerous vesicles (ve)  located in 
close proximity to  the Goigi  cisternae  (G).  Fig.  16  is  a  further enlargement  of part  of Fig.  15 
demonstrating both CF and IgG in Golgi cisternae. Specimen preparation as for Fig. 5 except that 
the cryostat section was incubated in peroxidase-conjugated anti-mouse IgG before staining in DAB. 
Fig.  14: ×  32,000.  Fig. 15: ×  57,000.  Fig.  16: ×  100,000. 
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size, they were rarely cut open, and the labeled antibody fragment was apparently 
unable to penetrate their membrane under the conditions used. It is of interest that 
staining  of the  small  Golgi-associated  vesicles and  of the  Golgi cisternae  was  less 
uniform and consistent than in plasma cells incubated in HRP. This could reflect the 
fact that the labeled antibody fragment, which must diffuse into the myeloma cells to 
achieve staining, is larger (80,000 mol wt) (19) than the HRP (40,000 mol wt) used as 
a probe in the case of the plasma cells. 
LOCALIZATION OF ARYL SULFATASE.  Tests for this lysosomal marker enzyme were 
carried out on RPC 5.4 myeloma cells to confirm the identity of lysosomal structures. 2 
Reaction  product  for aryl  sulfatase  was  restricted  to  typical  lysosomal  structures 
(dense bodies, multivesicular bodies, or vacuolar structures), which could usually be 
found  in  the  Golgi  region.  Reaction  product  was  not  seen  in  the  stacked  Golgi 
cisternae or in other Golgi-associated structures in these cells. 
Discussion 
The  main  finding  in  this  study  is  the  demonstration  that  in  immunoglobulin- 
secreting cells, membrane is continually retrieved from the cell surface and fuses with 
Golgi elements. We have demonstrated the existence of considerable membrane traffic 
from the cell surface to Golgi cisternae and secretory vacuoles as well as to lysosomes 
both in plasma cells obtained from lymph nodes and in cultured myeloma cells. The 
variations in membrane traffic and the pathways revealed with electron-dense tracers 
are quite comparable to those previously detected in anterior pituitary ceils (15,  16): 
all the tracers used were taken up by endocytosis, but those that mark the contents of 
endocytic vesicles (anionic ferritin and HRP) reached only lysosomes, whereas those 
that mark the membrane (CF) reached secretory compartments as well as lysosomes. 
Similar findings have also been reported in the thyroid gland (17). The most plausible 
explanation for this membrane traffic to the Golgi in immunoglobulin-secreting cells 
as well as in the other cell types mentioned is that it is connected with the recycling 
of secretory vacuole membrane-i.e., membrane added to the cell surface by exocytosis 
is assumed to be recovered by endocytosis and returned to the Golgi complex where 
it is reused as containers in the packaging of newly synthesized immunoglobulins.  8 
This assumption is supported by the fact that CF becomes located in compartments 
that also contain immunoglobulins (demonstrated by immunostaining) of cells known 
to be actively secreting proteins into the medium. 
CF is not an ideal membrane marker because its binding to membranes is based 
primarily on charge (electrostatic) interaction, and  thus the tracer is susceptible to 
detachment if the vesicle fuses with a compartment in which there is competition for 
binding with other acidic groups of  higher charge density than those on the membrane. 
For this reason, in this as in previous work with CF, we cannot be certain that  the 
membrane removed from the cell surface is the same membrane as that that ultimately 
z Tests for acid  phosphatase (with fl-glycerophosphate or cytidine  monophosphate as substrate) were 
also done, but this enzyme was not a  reliable lysosomal marker because it stained the cell  membrane and 
Golgi cisternae as well as lysosomes in these cells. 
a So far, we have been unable to obtain clear evidence for release of new secretory vesicles that contain 
CF because of difficulty in removing residual CF bound to the cell  surface. This is because (as reported 
earlier [15]), upon addition of CF, the cells stick together with a  monomolecular layer of CF in between, 
which we have not been able to entirely eliminate even after repeated washing with buffers of high ionic 
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appears marked with CF in the Golgi. Be that as it may, the fact is that because of its 
interaction (albeit weak) with the membrane, CF has revealed a membrane traffic in 
immunoglobulin-secreting cells and in several other cell types that had not previously 
been detected. To obtain more information on membrane recycling in secretory cells, 
what is needed at present are (a) stable (covalently bound), nonperturbing membrane 
labels, and  (b) systems amenable to their use and analysis. Our results indicate that 
appropriately  selected  myeloma  cell  lines  may  represent  suitable  and  promising 
systems in which to investigate membrane recycling in further detail because, (a) we 
have demonstrated the existence of membrane traffic in immunoglobulin-secreting 
cells similar to that in glandular cells, and (b) we have identified several myeloma cell 
lines  that  behave  like  normal  plasma  cells  with  respect  to  these  properties.  In 
particular, the availability of a homogeneous cell population that can be propagated 
in culture in large quantities makes this a more feasible system on which to carry out 
cell  fractionation and  subsequent  biochemical  studies  than  the  lobule  (14,  17)  or 
dissociated cell (15) systems used previously. 
There  is  now  abundant  evidence  (1-5)  that  plasma  cells  use  the  same  general 
pathway in the production of immunoglobulins as that used by exocrine and endocrine 
cells for production of their secretory products. Indeed, the only difference reported 
between plasma cells (as well as a few other cell types such as fibroblasts [6, 32]) and 
other secretory systems is the fact that secretion is continuous, and storage and release 
of immunoglobulins are unaffected by many of the known control mechanisms (e.g., 
cyclic nucleotides  and  extracellular  Ca2+).  Our  findings  provide evidence  for  yet 
another similarity between plasma  cells and  other secretory cells-i.e.,  the  recovery 
and handling of surface membrane. It should be mentioned, however, that recently 
Cohen et al.  (33)  have hypothesized that  there is undirectional  membrane flow in 
myeloma cells and that manufactured membrane is rapidly degraded. This conclusion 
was  based on data obtained on  myeloma cells  (MOPC  41), which  indicate that  a 
number of proteins of a microsomal membrane fraction (consisting of a heterogeneous 
mixture of ER, Golgi, and plasma membranes) turn over at the same rate. However, 
the  validity of this conclusion can  be questioned  for a  number of reasons:  (a)  the 
fractions examined were heterogeneous, (b)  the possibility that  the data reflect the 
turnover of viral  membrane proteins  (which  are concentrated in  the  ER)  was  not 
considered, and  (c)  the fact that  these myeloma cells are rapidly dividing and  in a 
state of exponential growth (rather than steady-state) complicates the interpretation 
of the data.  There is now reliable data obtained under steady-state conditions, on 
several  other  secretory  systems,  which  indicate  that  the  membranes  of secretory 
granules turnover at a much slower rate than that of their content. Thus, the recent 
turnover data (34, 35), as well as the data obtained with electron-dense tracers (14- 
18), suggest that granule membrane released during exocytosis is reused or recycled 
rather than being degraded. Other studies, notably those by Steinman et al. (36, 37), 
and Schneider et al.  (38)  provide evidence for the existence in cultured cells (macro- 
phages and fibroblasts) of recycling (plasmalemma ~  lysosomes --* plasmalemma) of 
membrane internalized by pinocytosis (36, 38) and phagocytosis (37). 
An interesting and novel finding obtained in this study was the demonstration that 
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cell suspension, the tracers are taken up  (for the most  part 4)  contained within the 
same endocytic vesicles, but they maintain their different destinations. These results 
could be explained if the incoming endocytic vesicles first fuse with lysosomes where 
they lose their content (containing HRP and any loosely bound or free ferritin) and 
the membrane with bound CF  moves on to the Golgi. This indirect route has the 
advantage that it provides a  means of preventing exogenous proteins from reaching 
the secretory compartment. 
In previous work from this laboratory on anterior pituitary cells (15), we made note 
of the fact that  the variations in  traffic detected with anionic and cationic ferritin 
could be explained either by the existence of two recovery routes (plasmalemma 
Golgi,  and  plasmalemma  ~  lysosomes),  or  by  a  single  recovery route  with  two 
stations,  the lysosomes being the first station  and  the Golgi being the second. The 
data obtained did not allow us to distinguish between these two possibilities. In the 
meantime, Herzog and Miller (17) have obtained data that indicate the existence of 
such an indirect Golgi route (plasmalemma ~  lysosomes ~  Golgi) in thyroid cells. 
On the other hand, studies on exocrine cells of the parotid (14) and the pancreas (18) 
indicate that  membrane recovery is  rapid  and  extensive with  little evidence for a 
lysosomal stopover, which  makes  it  likely that  the  direct  route  (plasmalemma 
Golgi) is used extensively in these cells. Thus, the most likely possibility at present is 
that in secretory cells both routes are used, and individual cell types divert the traffic 
according to their activities or functional state. 
Finally, a  word should be said about the importance of the net charge of tracers 
used in the study of endocytosis and membrane internalization as exemplified by our 
experience with  differently charged  ferritins.  Results  were  consistent  with  native 
ferritin, which, because of its net negative charge, does not bind to cell surfaces and 
acts strictly as a  content marker. In all systems studied to date (13-16) this form of 
the tracer appears only in lysosomes. Similarly, results appear straight forward with 
commercially available CF that carries a high net positive charge, binds to most cell 
membranes  (15,  17, 31), is selectively concentrated during endocytosis, and acts, at 
least  initially, as  a  membrane marker.  A  problem  arises,  however, with  the use of 
ferritins with a pI near neutrality (7.4-7.8): they bind to cell membranes to a variable 
degree depending upon such factors as the concentration of negatively charged sites 
on the cell type in question and the ionic strength of the medium in which exposure 
takes place. This variability in binding results in variability in subsequent intracellular 
distribution of the tracer. It seems likely that this same situation could arise with the 
use  of other  tracers or  in  using  ferritin  conjugates  in  which  the  charge  has  been 
modified during conjugation. 
Summary 
Evidence for recovery of surface membrane and its fusion with Golgi cisternae has 
been  obtained  previously in  several  glandular  cells.  This  study  was  conducted  to 
determine whether or not membrane is similarly retrieved from the surfaces of plasma 
cells from lymph nodes (of rats immunized with horseradish peroxidase [HRP]) and 
4 As  mentioned  in  the  Results,  a  few  vesicles  near  the  cell  surface contain  CF  alone.  It  cannot  be 
determined whether they are from regions of the free cell  surface where HRP has access  or from regions 
where HRP is excluded-i.e., those regions in which cells are in contact with a  monomolecular layer of CF 
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mouse  myeloma cells  (RPC  5.4  and  X63  Ag  8  cell  lines).  Electron-dense  tracers 
(cationic  and  anionic  ferritin,  HRP)  were used  to  trace the  pathways  followed  by 
surface membrane recovered by endocytosis, and immunocytochemistry was used to 
identify the secretory compartments. 
When plasma cells or myeloma cells were incubated with cationized ferritin  (CF), 
it bound to the cell surfaces and was taken up in endocytic vesicles, for the most part 
bound  to the vesicle membrane. After 30-60  min, it was found  increasingly within 
lysosomes and in several secretory compartments-notably in multiple stacked Golgi 
cisternae  and  secretory  vacuoles.  By  immunocytochemistry  the  secretory  product 
(immunoglobulins)  and CF could be demonstrated  in  the same Golgi components. 
When myetoma cells were incubated with native (anionic)  ferritin or in HRP, these 
tracers were  taken  up  in  much  smaller amounts,  primarily within  the  contents  of 
endocytic  vesicles.  With  continued  incubation,  they  appeared  only  in  lysosomes. 
When cells were doubly incubated,  first in CF and then in HRP, both tracers were 
taken up  (often within the same endocytic vesicle), but they maintained their same 
destinations  as when  incubated  in a  single tracer alone:  the content  marker, HRP, 
was localized exclusively within the lysosomal system, whereas the membrane marker, 
CF,  was  found  within  elements  along  the  secretory  pathway  as  well  as  within 
lysosomes. 
The findings demonstrate the existence of considerable membrane traffic between 
the cell membrane and the Golgi eisternae and lysosomes in both normal plasma cells 
and  myeloma cells.  Because  myeloma cells behave like  the  glandular  cells studied 
previously with regard to pathways of retrieved surface membrane, they represent a 
suitable  and  promising system for further studies  of mechanisms  and  pathways of 
membrane retrieval and recycling in secretory cells. 
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